{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:48:42Z","timestamp":1779918522759,"version":"3.53.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cancers may be treated by selective targeting of the genes vital for their survival. A number of attempts have led to discovery of several genes essential for surviving of tumor cells of different types. In this work, we tried to analyze genes that were previously predicted to be essential for melanoma surviving. Here we present the results of transient siRNA-mediated knockdown of the four of such genes, namely, UNC45A, STK11IP, RHPN2 and ZNFX1, in melanoma cell line A375, then assayed the cells for their viability, proliferation and ability to migrate in vitro. In our study, the knockdown of the genes predicted as essential for melanoma survival does not lead to statistically significant changes in cell viability. On the other hand, for each of the studied genes, mobility assays showed that the knockdown of each of the target genes accelerates the speed of cells migrating. Possible explanation for such counterintuitive results may include insufficiency of the predicting computational models or the necessity of a multiplex knockdown of the genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To examine the hypothesis of essentiality of hypomutated genes for melanoma surviving we have performed knockdown of several genes in melanoma cell line and analyzed cell viability and their ability to migrate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Knockdown was performed by siRNAs transfected by Metafectene PRO. The levels of mRNAs before and after knockdown were evaluated by RT-qPCR analysis. Cell viability and proliferation were assessed by MTT assay. Cell migration was assessed by wound healing assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The knockdown of the genes predicted as essential for melanoma survival does not lead to statistically significant changes in cell viability. On the other hand, for each of the studied genes, mobility assays showed that the knockdown of each of the target genes accelerates the speed of cells migrating.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results do not confirm initial hypothesis that the genes predicted essential for melanoma survival as a matter of fact support the survival of melanoma cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12935-020-01584-2","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T06:03:16Z","timestamp":1602050596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of candidate genes expected to be essential for melanoma surviving"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1743-3032","authenticated-orcid":false,"given":"Irina A.","family":"Krivosheeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Yu.","family":"Filatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei A.","family":"Moshkovskii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancha V.","family":"Baranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail Yu.","family":"Skoblov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"issue":"1","key":"1584_CR1","first-page":"7","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer Statistics 2017. CA: Cancer J Clin. 2017;67(1):7\u201330.","journal-title":"CA: Cancer J Clin"},{"key":"1584_CR2","first-page":"3923585","volume":"2016","author":"W Xu","year":"2016","unstructured":"Xu W, Beeharry MK, Liu W, Yan M, Zhu Z. Preoperative chemotherapy for gastric cancer: personal interventions and precision medicine. Biomed Res Int. 2016;2016:3923585.","journal-title":"Biomed Res Int"},{"issue":"7","key":"1584_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrd2081","volume":"5","author":"JW Shay","year":"2006","unstructured":"Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discovery. 2006;5(7):577\u201384.","journal-title":"Nat Rev Drug Discovery"},{"issue":"5777","key":"1584_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1126\/science.1125950","volume":"312","author":"RS Kerbel","year":"2006","unstructured":"Kerbel RS. Antiangiogenic therapy: a universal chemosensitization strategy for cancer? Science. 2006;312(5777):1171\u20135.","journal-title":"Science"},{"issue":"1","key":"1584_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/PAP.0000000000000006","volume":"21","author":"A Tulbah","year":"2014","unstructured":"Tulbah A, Chaudhri N, Al Dayel F, Akhtar M. The journey toward personalized cancer therapy. Adv Anat Pathol. 2014;21(1):36\u2013433.","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"1584_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/carcin\/bgt086","volume":"34","author":"K Masui","year":"2013","unstructured":"Masui K, Gini B, Wykosky J, Zanca C, Mischel PS, Furnari FB, et al. A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. Carcinogenesis. 2013;34(4):725\u201338.","journal-title":"Carcinogenesis"},{"issue":"10","key":"1584_CR7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1158\/1541-7786.MCR-13-0244","volume":"11","author":"M Ranzani","year":"2013","unstructured":"Ranzani M, Annunziato S, Adams DJ, Montini E. Cancer gene discovery: exploiting insertional mutagenesis. Mol Cancer Res. 2013;11(10):1141\u201358.","journal-title":"Mol Cancer Res"},{"key":"1584_CR8","doi-asserted-by":"publisher","first-page":"W416","DOI":"10.1093\/nar\/gku368","volume":"42","author":"HJ Lee","year":"2014","unstructured":"Lee HJ, Dang TC, Lee H, Park JC. OncoSearch: cancer gene search engine with literature evidence. Nucleic Acids Res. 2014;42:W416\u2013W421421.","journal-title":"Nucleic Acids Res"},{"issue":"7484","key":"1584_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505(7484):495\u2013501.","journal-title":"Nature"},{"issue":"11","key":"1584_CR10","doi-asserted-by":"publisher","first-page":"e0142819","DOI":"10.1371\/journal.pone.0142819","volume":"10","author":"M Pyatnitskiy","year":"2015","unstructured":"Pyatnitskiy M, Karpov D, Poverennaya E, Lisitsa A, Moshkovskii S. Bringing down cancer aircraft: searching for essential hypomutated proteins in skin melanoma. PLoS ONE. 2015;10(11):e0142819.","journal-title":"PLoS ONE"},{"issue":"10","key":"1584_CR11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng.2760","volume":"45","author":"TI Zack","year":"2013","unstructured":"Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013;45(10):1134\u201340.","journal-title":"Nat Genet"},{"issue":"1","key":"1584_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med. 2006;355(1):51\u2013655.","journal-title":"N Engl J Med"},{"key":"1584_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-0-387-77574-6_8","volume":"624","author":"U Leiter","year":"2008","unstructured":"Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer\u2013the role of sunlight. Adv Exp Med Biol. 2008;624:89\u2013103.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"1584_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00001622-199403000-00011","volume":"6","author":"JM Elwood","year":"1994","unstructured":"Elwood JM, Koh HK. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol. 1994;6(2):179\u201387.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"1584_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.hoc.2014.02.010","volume":"28","author":"VC Gorantla","year":"2014","unstructured":"Gorantla VC, Kirkwood JM. State of melanoma: an historic overview of a field in transition. Hematol Oncol Clin North Am. 2014;28(3):415\u201335.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7457","key":"1584_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214\u20138.","journal-title":"Nature"},{"key":"1584_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/978-1-4939-2291-8_25","volume":"1269","author":"A Lagana","year":"2015","unstructured":"Lagana A, Veneziano D, Russo F, Pulvirenti A, Giugno R, Croce CM, et al. Computational design of artificial RNA molecules for gene regulation. Methods Mol Biol. 2015;1269:393\u2013412.","journal-title":"Methods Mol Biol"},{"key":"1584_CR18","first-page":"17","volume":"3","author":"JV Vyakhireva","year":"2017","unstructured":"Vyakhireva JV, Filatova AY, Krivosheeva IA, Skoblov MY. siRNA-mediated gene silencing. B Russ State Med U. 2017;3:17\u201329.","journal-title":"B Russ State Med U"},{"issue":"1","key":"1584_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156\u20139.","journal-title":"Anal Biochem"},{"key":"1584_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-5538-z","author":"DO Konina","year":"2019","unstructured":"Konina DO, Filatova AY, Skoblov MY. LINC01420 RNA structure and influence on cell physiology. BMC Genomics. 2019. https:\/\/doi.org\/10.1186\/s12864-019-5538-z.","journal-title":"BMC Genomics"},{"issue":"1","key":"1584_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","volume":"121","author":"R Kim","year":"2007","unstructured":"Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121(1):1\u201314.","journal-title":"Immunology"},{"issue":"48","key":"1584_CR22","doi-asserted-by":"publisher","first-page":"18238","DOI":"10.1073\/pnas.0607057103","volume":"103","author":"JH Bielas","year":"2006","unstructured":"Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA. Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A. 2006;103(48):18238\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1584_CR23","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1096\/fj.08-108985","volume":"22","author":"CH Yeang","year":"2008","unstructured":"Yeang CH, McCormick F, Levine A. Combinatorial patterns of somatic gene mutations in cancer. FASEB J. 2008;22(8):2605\u201322.","journal-title":"FASEB J"},{"issue":"7267","key":"1584_CR24","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071\u20138.","journal-title":"Nature"},{"issue":"8","key":"1584_CR25","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1073\/pnas.1213968110","volume":"110","author":"CD McFarland","year":"2013","unstructured":"McFarland CD, Korolev KS, Kryukov GV, Sunyaev SR, Mirny LA. Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci U S A. 2013;110(8):2910\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 21","key":"1584_CR26","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1242\/jcs.00108","volume":"115","author":"MG Price","year":"2002","unstructured":"Price MG, Landsverk ML, Barral JM, Epstein HF. Two mammalian UNC-45 isoforms are related to distinct cytoskeletal and muscle-specific functions. J Cell Sci. 2002;115(Pt 21):4013\u201323.","journal-title":"J Cell Sci"},{"issue":"17","key":"1584_CR27","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1182\/blood-2014-03-563981","volume":"124","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Moschetta M, Huynh D, Tai YT, Zhang Y, Zhang W, et al. Pyk2 promotes tumor progression in multiple myeloma. Blood. 2014;124(17):2675\u201386.","journal-title":"Blood"},{"issue":"10","key":"1584_CR28","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3748\/wjg.v9.i10.2160","volume":"9","author":"GB Qiu","year":"2003","unstructured":"Qiu GB, Gong LG, Hao DM, Zhen ZH, Sun KL. Expression of MTLC gene in gastric carcinoma. World J Gastroenterol. 2003;9(10):2160\u20133.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1584_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00726-004-0084-6","volume":"26","author":"B Cadot","year":"2004","unstructured":"Cadot B, Rufini A, Pietroni V, Ramadan S, Guerrieri P, Melino G, et al. Overexpressed transglutaminase 5 triggers cell death. Amino Acids. 2004;26(4):405\u20138.","journal-title":"Amino Acids"},{"issue":"14","key":"1584_CR30","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1074\/jbc.RA118.006597","volume":"294","author":"NH Eisa","year":"2019","unstructured":"Eisa NH, Jilani Y, Kainth K, Redd P, Lu S, Bougrine O, et al. The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis. J Biol Chem. 2019;294(14):5246\u201360.","journal-title":"J Biol Chem"},{"issue":"2","key":"1584_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/1541-7786.MCR-18-0670","volume":"17","author":"A Mooneyham","year":"2019","unstructured":"Mooneyham A, Iizuka Y, Yang Q, Coombes C, McClellan M, Shridhar V, et al. UNC-45A is a novel microtubule-associated protein and regulator of paclitaxel sensitivity in ovarian cancer cells. Mol Cancer Res. 2019;17(2):370\u201383.","journal-title":"Mol Cancer Res"},{"issue":"25","key":"1584_CR32","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1093\/hmg\/10.25.2869","volume":"10","author":"DP Smith","year":"2001","unstructured":"Smith DP, Rayter SI, Niederlander C, Spicer J, Jones CM, Ashworth A. LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1. Hum Mol Genet. 2001;10(25):2869\u201377.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1584_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41422-019-0161-8","volume":"29","author":"LR Pelgrom","year":"2019","unstructured":"Pelgrom LR, Patente TA, Sergushichev A, Esaulova E, Otto F, Ozir-Fazalalikhan A, et al. LKB1 expressed in dendritic cells governs the development and expansion of thymus-derived regulatory T cells. Cell Res. 2019;29(5):406\u201319.","journal-title":"Cell Res"},{"issue":"69","key":"1584_CR34","doi-asserted-by":"publisher","first-page":"113847","DOI":"10.18632\/oncotarget.22943","volume":"8","author":"W Zhang","year":"2017","unstructured":"Zhang W, Yin L, Song G, Han X, Yin Z, Luo D. LKB1 loss cooperating with BRAF V600E promotes melanoma cell invasion and migration by up-regulation MMP-2 via PI3K\/Akt\/mTOR pathway. Oncotarget. 2017;8(69):113847\u201357.","journal-title":"Oncotarget"},{"issue":"16","key":"1584_CR35","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1158\/0008-5472.CAN-13-1168-T","volume":"73","author":"C Danussi","year":"2013","unstructured":"Danussi C, Akavia UD, Niola F, Jovic A, Lasorella A, Pe'er D, et al. RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation. Can Res. 2013;73(16):5140\u201350.","journal-title":"Can Res"},{"issue":"46","key":"1584_CR36","doi-asserted-by":"publisher","first-page":"43924","DOI":"10.1074\/jbc.M203569200","volume":"277","author":"JW Peck","year":"2002","unstructured":"Peck JW, Oberst M, Bouker KB, Bowden E, Burbelo PD. The RhoA-binding protein, rhophilin-2, regulates actin cytoskeleton organization. J Biol Chem. 2002;277(46):43924\u201332.","journal-title":"J Biol Chem"},{"issue":"8","key":"1584_CR37","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/cancers12082154","volume":"12","author":"Y Tang","year":"2020","unstructured":"Tang Y, Durand S, Dalle S, Caramel J. EMT-inducing transcription factors, drivers of melanoma phenotype switching, and resistance to treatment. Cancers. 2020;12(8):2154.","journal-title":"Cancers"},{"issue":"11","key":"1584_CR38","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41556-019-0416-0","volume":"21","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yuan S, Jia X, Ge Y, Ling T, Nie M, et al. Mitochondria-localised ZNFX1 functions as a dsRNA sensor to initiate antiviral responses through MAVS. Nat Cell Biol. 2019;21(11):1346\u201356.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"1584_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/CMR.0000000000000595","volume":"29","author":"L Liang","year":"2019","unstructured":"Liang L, Zhang Z, Qin X, Gao Y, Zhao P, Liu J, et al. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p\/RAB9A in melanoma. Melanoma Res. 2019;29(6):569\u201381.","journal-title":"Melanoma Res"},{"issue":"4","key":"1584_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18097\/PBMC20186404303","volume":"64","author":"MA Pyatnitskiy","year":"2018","unstructured":"Pyatnitskiy MA, Karpov DS, Moshkovskii SA. Searching for essential genes in cancer genomes. Biomed Khim. 2018;64(4):303\u201314.","journal-title":"Biomed Khim"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-020-01584-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-020-01584-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-020-01584-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T22:43:14Z","timestamp":1633560194000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-020-01584-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1584"],"URL":"https:\/\/doi.org\/10.1186\/s12935-020-01584-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-43507\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-43507\/v1","asserted-by":"object"}]},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"14 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"488"}}